Hybrid immunity against COVID-19 in different countries with a special emphasis on the Indian scenario during the Omicron period

Hybrid immunity has been accepted as the most robust immunity to fight against SARS-CoV-2. The hybrid immunity against the virus is produced in individuals who have contracted the disease and received the COVID-19 vaccine. This happens due to the cumulative effect of natural and acquired (vaccine) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhattacharya, Manojit, Sharma, Ashish Ranjan, Dhama, Kuldeep, Agoramoorthy, Govindasamy, Chakraborty, Chiranjib
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986476/
https://www.ncbi.nlm.nih.gov/pubmed/35413676
http://dx.doi.org/10.1016/j.intimp.2022.108766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986476/
https://www.ncbi.nlm.nih.gov/pubmed/35413676
http://dx.doi.org/10.1016/j.intimp.2022.108766

Ejemplares similares